Skip to main content
Call 24/7: 1-800-400-1805
1-800-400-1805 Free Case Review
Sign In Join Free

is meso always a death sentence or are people actually surviving longer now

Family · · 69 views
So Joe got his diagnosis in September and I'll be honest, those first few weeks I was googling everything at 2am and all I could find were the scary statistics. But we're almost three months into his immunotherapy now and I'm starting to see a different picture.

I was a teacher for 32 years, right, and I learned early on that statistics don't tell the whole story. A class average of 75% doesn't mean every kid scored 75. Some scored higher. Some lower. Meso feels the same way to me now.

The thing is, the numbers people see online are often from studies that are like five or ten years old. Treatment has changed a lot since then. Immunotherapy wasn't even standard when a lot of those survival stats came from. And multimodal treatment, which is what Joe's doing, seems to be giving people more time than surgery alone or chemo alone ever did.

I'm not gonna sit here and tell you meso isn't serious because it absolutely is. But "always fatal" feels like it's missing the part where people are living two years, three years, sometimes longer. That's not nothing. That's time. That's holidays and grandkids and moments.

Joe's stage III, which is not early, and his doctors are talking about quality of life and extending his timeline, not just accepting the worst case. That was a huge shift for me mentally. Are there people here who've been living with this for a while? I'd love to hear how you're thinking about it now.

11 Replies

Patient
Hey, good to hear Joe's getting the multimodal treatment going. That's the ticket right there. I'm stage I so obviously different ballgame, but I can tell you the docs caught mine pretty early last December and we did the EPP surgery back in February. Recovery went pretty smooth, all things considered, and now we're doing the tune-up chemo rounds to make sure we got it all.

What you're saying about the old statistics, that tracks with me 100%. My oncologist at Henry Ford showed me some data from like 2015 and then newer stuff from 2024 and it's night and day. The immunotherapy combos especially seem to be changing the game. Like when my surgeon told me in February that we caught it before it spread real bad, I felt like I'd gotten the last good part at the junkyard, you know.

The thing that helped me was talking to people who were actually living it now, not just reading studies from when my dad was still working on cars. There's definitely people here doing better than the internet doom spiral suggests. Hang in there with Joe through the chemo, those infusions can be rough but sounds like his team's got a solid plan.
Family
You're hitting on something really important here. Those old statistics haunted me too during those first weeks, and I remember sitting at my kitchen table at like 3am with my laptop thinking "okay so what's the actual current picture." The stuff from 2015 and 2016 doesn't account for what's happening now with immunotherapy combinations and better supportive care.

Joe being stage III and having access to multimodal treatment puts him in a different position than someone diagnosed ten years ago would've been. It's not magic, but it matters. We started his immunotherapy in November and honestly just seeing him have days where he feels decent and can do things... that changes how you think about the timeline. Instead of "how much time does he have left" it became "what can we do with the time he has."

I taught long enough to see the same thing with test scores and prognoses, right. Individual outliers matter. Some kids who scored below average ended up doing amazing things. Some students everyone expected to fly struggled. The group average never tells you what one person's actually going to do.

What's been wild for us is connecting with others further along who've been living with this for years now. Not everyone, but some people. They're out there. And hearing from them that quality of life is totally possible, that you can still travel and laugh and have good days... that's information the scary statistics don't give you.

How's Joe handling the immunotherapy side effects so far?
Family
honestly this is exactly where my head's at with my dad right now. he's stage IV so obviously different situation, but his oncologist keeps saying the same thing about how much the treatment landscape has shifted even in just the last few years, and that helps more than I expected it to.
Medical ✓ Expert Response
What you wrote about statistics is something I find myself saying in support groups all the time. Median survival is the middle of a range, and that range has genuinely shifted in the last few years. The KEYNOTE-789 trial data showed real improvement in overall survival for patients on pembrolizumab combinations, and that's the kind of research that hasn't made it into most of the articles people are finding at 2am yet.

Joe's framing matters too, and so does yours. I've sat with families where the shift from "how long" to "how well" changed everything about how they experienced the weeks ahead. That's not denial. That's a clinically supported approach to living with serious illness.

Stage III with a team that's talking quality of life and multimodal treatment... that's actually a hopeful picture. Not a naive one.

I do want to say gently, if those 2am google sessions are still happening and the anxiety is sitting heavy, talking to someone who specializes in oncology support can help. Not because anything is wrong with how you're coping, just because you deserve support too, not only Joe. A lot of cancer centers have social work services built right in and they're often free of charge.

The people in this community who've been living with meso for two, three, four years are real. Keep asking to hear from them.
3 found this helpful
Family
Oh Amy, thank you for bringing up KEYNOTE-789 because that's actually one of the studies Joe's oncologist mentioned when we were deciding on his treatment plan. It made such a difference knowing there was actual recent data behind what they were recommending, not just hope. And yeah, the 2am googling phase was rough until I realized I was mostly finding outdated information. Your point about the range shifting really does matter when you're sitting there trying to understand what "median" actually means for your person. How long have you been doing this work in the support groups?
Medical ✓ Expert Response
You're reading this exactly right, and your teacher analogy is genuinely one of the better framings I've heard for how statistics work in oncology.

The numbers most people find when they're up at 2am are pulled from SEER database entries that often reflect diagnoses from 2010 to 2015, before nivolumab plus ipilimumab (the combination Joe may be on) became standard of care. The CheckMate 743 trial, which is what changed first-line treatment for pleural mesothelioma, showed a median overall survival of 18.1 months versus 14.1 with chemo. That's the median. Which means a real portion of patients did considerably better than that.

Stage III is genuinely hard, I won't minimize it. But "stage III" also covers a wide range of disease burden, and in clinic I've watched patients with significant disease respond in ways that surprised everyone, including me.

The multimodal piece matters too. There's growing data from places like the International Mesothelioma Interest Group showing that combining systemic therapy with careful locoregional management is extending functional, good-quality time in ways the older literature just couldn't reflect.

What I'd want to know, if I were in your position, is whether Joe's team has discussed his PD-L1 expression levels or any biomarker profiling, because that can sometimes tell you more about likely response than stage alone. That's a conversation worth having with his oncologist specifically.

The people living three, four, five years out are real. They don't always show up in the statistics because the studies that produced those statistics were already closed.
3 found this helpful
Family
Oh wow, thank you for actually backing that up with the trial name. I've been trying to remember what to tell people when they bring up those old statistics and CheckMate 743 is exactly what I needed. It's so different when someone explains it in real terms instead of just saying "things have improved."

Is Joe on that combo? His oncologist mentioned it but I want to make sure I'm understanding what he's actually getting.
Patient
Yeah man, I get what you're saying about the stats. Caught mine early last December, stage I, and even then I was down the google rabbit hole at like 3am convinced I was done for. My doc at the time, he was kinda doom and gloom, and I almost believed him til I got a second opinion from someone who actually does EPP surgery regular.

Had the surgery back in February and honestly the recovery went way better than I expected. Like I thought I'd be laid up for months but I'm doing pretty good now, couple months out. Still got my follow-up chemo schedule coming up but the fact that they caught mine early and went aggressive with it instead of just palliative care, that changes everything. My surgeon told me the guys he sees who get multimodal treatment are living way longer than the old numbers suggest.

You're right about the old data too. When I was working on cars back in the 70s and 80s, brake pads had asbestos in em and nobody knew anything about it. But the treatments back then were basically just trying to make you comfortable. Now they got immunotherapy, they got surgery that actually removes the lining, they can combine treatments. It's not the same ballgame.

Joe's doing the right thing with multimodal. That's the ticket. And honestly the fact that his docs are talking timeline extension instead of just... well, you know, that tells me they think he's got real options. Doesn't mean it's easy but it means it ain't hopeless either.
Medical ✓ Expert Response
You're reading this exactly right, and your teacher analogy is genuinely one of the better ways I've heard someone frame it.

The statistics that show up on the first page of Google are often pulled from SEER database cohorts that predate 2015, before nivolumab plus ipilimumab (the combination Joe may be on) became a real option. The CheckMate 743 trial, published in the Lancet in 2021, showed median overall survival of 18.1 months with that combination versus 14.1 with chemotherapy. And "median" means half the patients did better than that. Some meaningfully better.

Stage III is not stage IV. That distinction matters more than people realize. And multimodal approaches, where a team is coordinating immunotherapy alongside other interventions rather than just picking one tool, genuinely changed what we started seeing in our clinic around 2019 or so. I had a patient, a 71 year old former shipyard worker, who was 38 months out from a stage III pleural diagnosis when I last checked in with him. I can't promise that for Joe, and his own oncologist knows his case far better than I do. But I bring it up because that number exists.

The mental shift you described, from worst case acceptance to quality of life and timeline extension, that's not denial. That's actually the more medically accurate frame for where treatment is right now. Oncology has moved toward thinking of some aggressive cancers as chronic conditions to be managed, not just countdowns.

Please do keep talking to Joe's oncology team about what the data looks like specifically for his histological subtype (epithelioid tends to respond better to immunotherapy than sarcomatoid) because those details change everything.
2 found this helpful
Family
Oh wow, thank you so much for jumping in on this. That CheckMate trial number really helps put things in perspective, especially since that's exactly what Joe's doing. Hearing "18.1 months" versus what the old studies say feels like actual hope instead of just me trying to convince myself things are better. And yeah, you nailed it about the median thing, my brain was already going there about how that means some people are doing better than that baseline. Do you see patients where the combination immunotherapy is extending things even further than those numbers, or is that still pretty early to tell?
Patient
I appreciate what you're saying about the statistics because you're right, they're outdated. My diagnosis was November 2025 and I've already noticed my oncologist referencing studies from 2020, 2021 at the latest. The field has shifted dramatically even in that short window.

I'm Stage II peritoneal, so different from Joe's situation, but I've been doing exactly what you did those first weeks. I created a whole spreadsheet tracking median survivals by stage and treatment type, cross-referenced it with publication dates, looked at the methodology. The older data is heavily weighted toward patients who didn't get the benefit of modern immunotherapy combinations. When you pull out just the studies from 2023 onward with multimodal approaches, the numbers genuinely look different.

What's been helpful for me is talking to my surgical oncologist about my specific case rather than just absorbing the aggregate statistics. I worked in an insulation factory from 1978 to 1985, so my exposure was significant and my latency period was long, which unfortunately tracks with worse prognosis. But I'm evaluating HIPEC surgery right now and my team seems genuinely optimistic about extending both quantity and quality of life. They're not painting rosy pictures, but they're also not acting like this is hopeless.

The thing that shifted for me was realizing I was comparing my 2025 diagnosis to data from people treated in 2015. That's a decade of progress in immunotherapy that I wasn't properly accounting for. Joe's multimodal approach is actually the current standard for a reason. It works better than what came before.

How's Joe tolerating the immunotherapy so far? Side effects wise, I mean.

Share Your Experience

Sign in or create a free account to share your experience.

Sign In Create Account

Discussions in this community are for informational and emotional support purposes only. They do not constitute legal advice, medical advice, or an attorney-client relationship. Always consult a qualified professional for advice specific to your situation. Community Guidelines

Call Now: (800) 400-1805 Free Case Review • Available 24/7